Lucite deal toy celebrating a development and commercialization agreement between Click Therapeutics and Boehringer Ingelheim. The collaboration centers on a prescription digital therapeutic for schizophrenia. (22AKL597)
Lucite deal toy celebrating a development and commercialization agreement between Click Therapeutics and Boehringer Ingelheim. The collaboration centers on a prescription digital therapeutic for schizophrenia. (22AKL597)
Crystal deal toy celebrating a strategic investment in Plano, Texas-based PSN Group. PSN is a system of ambulatory surgical centers (ASCs) and surgical hospitals. (22AKL495)
Crystal financial tombstone celebrating the launch of a fund by New York-based healthcare venture capital firm HC9 Ventures. The fund will focus on early-stage healthcare startups. (22AZH168)
Custom Lucite tombstone, including a spinning logo, celebrating the merger of St. Louis-based companies Navvis and Esse Health. (22AZH265)
Crystal tombstone marking the sale of a royalty for cancer drug Zejula. (22AKL516)
Crystal deal toy marking the acquisition of a royalty interest in global sales of pegcetacoplan, marketed under the brand names Empaveli and Aspavell. The drugs were developed for treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH), a rare blood disorder. (22AKL517)
Crystal deal toy celebrating a funding round for behavioral health company Forge Health. Based in White Plains, New York, Forge provides outpatient mental health and substance abuse treatment. (22AZH166)
Lucite tombstone marking the acquisition of Galbraith Laboratories. Based in Knoxville, Tennessee, the company provides testing services to a number of sectors including healthcare, chemicals, and cosmetics. (22AJH131)
Lucite tombstone recognizing the acquisition of GeneTx BioTherapeutics. GeneTx has focused on a therapy for Angelman syndrome, a rare neurogenic disease. (22ALJ280)
